Overexpression of RIOK2 in bladder urothelial carcinoma (BLCA), ESCA, HNSC, KIRP, LIHC, and THCA was strongly associated with poor patient outcomes. The gene discussed is RIOK2; the disease is bladder transitional cell carcinoma.